Science&Tech

Science-led innovation in synthetic bone grafting. We empower surgeons with next-generation biomaterials designed for predictable regeneration and long-term clinical success.

Driven by Clinical Science

LoLahop® technology originates from top-tier orthopedic research. Our focus is on the biological interaction between biomaterials and host bone, ensuring optimal healing through rigorous scientific validation.

Patented Biomimetic Tech

LoLahop® β–TCP

LoLahop® β–TCP Bioceramic (YY/T 0683 Compliant): Features a hierarchical porous structure engineered for osteocyte migration and balanced biodegradation. Gamma-sterilized for clinical safety.

High Porosity 70%±10%

Provides maximum surface area for osteoblast adhesion and proliferation.

Precision Pore Size (90-500μm Macro、 1-10μm Micro)

The optimal range for capillary ingrowth and nutrient transport.

NMPA Class III Certified

LoLahop® β--TCP is a human-grade synthetic bone biomaterial compliant with YY/T 0683 standards. As one of the few Class III registered bone grafts for veterinary use, it ensures uncompromising safety and superior osteogenic effects compared to leading global brands.

70% Interconnected Porosity

Engineered with a total porosity of 70%±10%, and an open porosity rate greater than 50%. This hierarchical, well-connected pore structure mimics natural bone, providing the ideal scaffold for rapid osteocyte migration and effective vascularization.

Synchronized Bio-Resorption

Features a controlled degradation cycle of 6–24 months, perfectly balanced with new bone ingrowth. During resorption, it releases essential calcium and phosphate ions to fuel bone regeneration, eventually being fully replaced by healthy host bone.

Global Patents & Certifications

Certified innovation built on intellectual property and rigorous clinical validation. We secure long-term clinical success through internationally recognized patents and premium regulatory standards.